Literature DB >> 26835109

Anticoagulation in Atrial Fibrillation - Current Concepts.

Demosthenes G Katritsis1, Bernard J Gersh2, A John Camm3.   

Abstract

This article presents the current status of the use of anticoagulation for the treatment of AF, particularly with the use of non-vitamin K-dependent anticoagulants. Comparisons between these agents and warfarin are made and methods for assessment of anticoagulant activity and reversal are discussed.

Entities:  

Keywords:  Atrial fibrillation; anticoagulants; guidelines; thromboprophylaxis

Year:  2015        PMID： 26835109      PMCID： PMC4711523          DOI： 10.15420/aer.2015.04.02.100

Source DB:  PubMed          Journal:  Arrhythm Electrophysiol Rev        ISSN： 2050-3369


  55 in total

1.  Risk of bleeding with dabigatran in atrial fibrillation.

Authors:  Inmaculada Hernandez; Seo Hyon Baik; Antonio Piñera; Yuting Zhang
Journal:  JAMA Intern Med       Date:  2015-01       Impact factor: 21.873

Review 2.  Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation.

Authors:  S Ben Freedman; Bernard J Gersh; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2014-12-29       Impact factor: 29.983

Review 3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

4.  European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.

Authors:  Hein Heidbuchel; Peter Verhamme; Marco Alings; Matthias Antz; Werner Hacke; Jonas Oldgren; Peter Sinnaeve; A John Camm; Paulus Kirchhof
Journal:  Europace       Date:  2013-05       Impact factor: 5.214

5.  Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients.

Authors:  Bob Weijs; Yuri Blaauw; Roger J M W Rennenberg; Leon J Schurgers; Carl C M M Timmermans; Laurent Pison; Robby Nieuwlaat; Leonard Hofstra; Abraham A Kroon; Joachim Wildberger; Harry J G M Crijns
Journal:  Eur Heart J       Date:  2011-07-20       Impact factor: 29.983

6.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

7.  The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.

Authors:  Stuart J Connolly; Lars Wallentin; Michael D Ezekowitz; John Eikelboom; Jonas Oldgren; Paul A Reilly; Martina Brueckmann; Janice Pogue; Marco Alings; John V Amerena; Alvaro Avezum; Iris Baumgartner; Andrzej J Budaj; Jyh-Hong Chen; Antonio L Dans; Harald Darius; Giuseppe Di Pasquale; Jorge Ferreira; Greg C Flaker; Marcus D Flather; Maria Grazia Franzosi; Sergey P Golitsyn; David A Halon; Hein Heidbuchel; Stefan H Hohnloser; Kurt Huber; Petr Jansky; Gabriel Kamensky; Matyas Keltai; Sung Soon Kim; Chu-Pak Lau; Jean-Yves Le Heuzey; Basil S Lewis; Lisheng Liu; John Nanas; Razali Omar; Prem Pais; Knud E Pedersen; Leopoldo S Piegas; Dimitar Raev; Pal J Smith; Mario Talajic; Ru San Tan; Supachai Tanomsup; Lauri Toivonen; Dragos Vinereanu; Denis Xavier; Jun Zhu; Susan Q Wang; Christine O Duffy; Ellison Themeles; Salim Yusuf
Journal:  Circulation       Date:  2013-06-14       Impact factor: 29.690

8.  Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients.

Authors:  Raffaele Marfella; Ferdinando Carlo Sasso; Mario Siniscalchi; Mario Cirillo; Pasquale Paolisso; Celestino Sardu; Michelangela Barbieri; Maria Rosaria Rizzo; Ciro Mauro; Giuseppe Paolisso
Journal:  J Am Coll Cardiol       Date:  2013-05-15       Impact factor: 24.094

9.  Edoxaban versus warfarin in patients with atrial fibrillation.

Authors:  Robert P Giugliano; Christian T Ruff; Eugene Braunwald; Sabina A Murphy; Stephen D Wiviott; Jonathan L Halperin; Albert L Waldo; Michael D Ezekowitz; Jeffrey I Weitz; Jindřich Špinar; Witold Ruzyllo; Mikhail Ruda; Yukihiro Koretsune; Joshua Betcher; Minggao Shi; Laura T Grip; Shirali P Patel; Indravadan Patel; James J Hanyok; Michele Mercuri; Elliott M Antman
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

10.  Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation.

Authors:  Paul Dorian; Thitima Kongnakorn; Hemant Phatak; Dale A Rublee; Andreas Kuznik; Tereza Lanitis; Larry Z Liu; Uchenna Iloeje; Luis Hernandez; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2014-02-09       Impact factor: 29.983
View more
  1 in total

Review 1.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.